NATIXIS

Position in PCRX — Pacira BioSciences, Inc.

CIK 1274981 PARIS, I0

Position in PCRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$768,400

-$111,520 QoQ

Shares Held

34,000

0.0% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIXIS holds $42,325,153 across 10 Drug Manufacturers - Specialty & Generic names. PCRX ranks #4 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	281,576	$33,285,098
2	SUPN	Supernus Pharmaceuticals, Inc.	85,200	$4,403,988
3	VTRS	Viatris Inc	134,531	$1,817,513
4	PCRX	Pacira BioSciences, Inc. This page	34,000	$768,400
5	UTHR	UNITED THERAPEUTICS Corp	1,175	$696,751
6	EOLS	Evolus, Inc.	141,437	$581,306
7	TEVA	Teva Pharmaceutical Industries Ltd	13,589	$409,300
8	NBIX	Neurocrine Biosciences Inc	2,647	$348,715

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$768,400	34,000	0.0%	Shares	Sole	2026-05-14
2025-12-31	$879,920	34,000	-72.6%	Shares	Sole	2026-02-13
2025-09-30	$3,192,903	123,900	-18.1%	Shares	Sole	2025-11-14
2025-06-30	$3,616,070	151,300	+302500.0%	Shares	Sole	2025-08-13
2025-03-31	$1,242	50	-99.9%	Shares	Sole	2025-07-18
2024-12-31	$1,737,990	92,250	-22.0%	Shares	Sole	2025-02-13
2024-06-30	$3,383,132	118,250	+3538.5%	Shares	Sole	2024-08-13
2024-03-31	$94,965	3,250	-84.9%	Shares	Sole	2024-05-13
2023-09-30	$659,620	21,500	+38.7%	Shares	Sole	2023-11-14
2023-06-30	$621,085	15,500	-45.6%	Shares	Sole	2023-08-11
2023-03-31	$1,163,085	28,500	+12.9%	Shares	Sole	2023-05-12
2022-09-30	$1,343,047	25,250	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.